NANBIOSIS Unit 26 will present its NMR and metabolomics capabilities in a free seminar at Universitat de València on 2 July 2026.
Valencia, July 2026 — On Thursday, 2 July 2026, researchers, students, and healthcare professionals will have the opportunity to learn more about the biomedical applications of nuclear magnetic resonance and metabolomics during the seminar “Biomedical Imaging and Metabolomics Section: Our Experience”.
The event will take place at 13:00 in Seminar Room D, on the main floor of the Faculty of Medicine and Dentistry at the Universitat de València. It is organized by the Biomedical Imaging and Metabolomics Section of the Central Research Unit in Medicine (UCIM).
The seminar will present the equipment available in the section, with special emphasis on recent improvements, updates, and their biomedical applications. In particular, the session will highlight the capabilities associated with NANBIOSIS Unit 26 – NMR: Biomedical Applications II, a key infrastructure for biomedical research based on nuclear magnetic resonance and related analytical techniques.
Attendees will learn more about the following services and technologies, all particularly oriented towards their biomedial application.
With regard to the Imaging Platform:
- Magnetic Resonance Imaging (MRI-3T)
- PET/CT (Positron Emission Tomography / Computed Tomography)
- IVIS (In Vivo Imaging System)
- Irradiator
With regard to the Metabolomic Platform:
- Chromatographic techniques
- 600 MHz NMR spectroscopy
- Hematology and biochemistry analyses
These tools support research in metabolism, biomarker discovery, and the study of disease-related biological processes, helping to advance biomedical research and translational applications.
The seminar will be delivered by Carlos Ezquer Garin and Mustafa Ezzeddin Ayoub (Musta), Senior Technicians of the Biomedical Imaging and Metabolomics Section at UCIM, Faculty of Medicine and Dentistry, Universitat de València.
Those interested in attending are invited to confirm their participation by contacting musez[at]uv.es. Alternativelly, you can also reach out through our contact form and we will forward your application directly to the Unit.
Through initiatives such as this seminar, NANBIOSIS continues to promote access to advanced research infrastructure and strengthen collaboration in the biomedical sciences.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
If you want to collaborate with us, visit our Order Request page.
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
